Scientists have developed a new type of CAR T cell therapy that could be more effective in treating multiple myeloma, a type of blood cancer. This new therapy uses...
Scientists have developed a new immunotherapy approach for cholangiocarcinoma (CCA), a type of cancer that originates in the bile ducts. The researchers identified neoantigens, which are unique markers found...
Image by frolicsomepl/pixabay Research Topics – Hematopoietic Stem cell mobilization by Using Ara-C– NK activity in Hematologic malignancies– Distribution of NK cell and MSC after Intravenous infusion – Prevention...
Image by Erin_Hinterland/pixabay A groundbreaking study has delved into the potential interactions between cannabidiol (CBD) and CD19-chimeric antigen receptor (CAR) T cell therapy, a promising approach in cancer immunotherapy....
2023 Frontiers in Basic Immunology The Center for Cancer Research at the National Cancer Institute is hosting a two-day international symposium on September 27-28, 2023 entitled 2023 Frontiers in...
Thailand Hub of Talent for Cancer Immunotherapy International Conference: Portal to Global Collaboration for Next Generation Cell and Gene Therapy Development Date: 16-17th November 2023Venue: Bhumisiri Mangklanusorn Building, Faculty...
Image by Herney/pixabay In a notable advancement in cell engineering research, scientists have developed the first ligand-based, piggyBac-transfected anti-EGFR CAR-T cells, targeting non-small cell lung cancer (NSCLC). NSCLC often...